Vasculitis & polymyalgia rheumatica
Turkish Society for Rheumatology recommendations for the diagnosis, follow-up and management of giant cell arteritis
Methodological detailsrecommendations, systematic literature review (PRISMA), PICO format, Oxford system for grading evidence and strength of recommendation
- Recommendations
- Systematic literature review (PRISMA)
- PICO format
- Oxford system for grading evidence and strength of recommendation
Recommendations
As issued by the authors
MTX in addition to GC as first-line treatment in all patients with giant cell arteritis (GCA) without ischaemic symptoms
LEF, AZA and MMF as alternatives in these patients if MTX is not tolerated
Tocilizumab in GCA patients with ischaemic symptoms or with refractoriness to at least one conventional immunosuppressive
Upadacitinib as an alternative to tocilizumab in patients with low cardiovascular risk
Original publication
Turkish Society for Rheumatology recommendations for the diagnosis, follow-up and management of giant cell arteritis. Clin Exp Rheumatol. Published 21 December 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →